Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $2.6K | $967.7K | $9.8M | $8.3M | $18.2M |
| Cost of revenue | $0 | $0 | $0 | $1.3K | $287.0K | $5.1M | $4.6M | $10.8M |
| Gross profit | $0 | $0 | $0 | $1.3K | $680.7K | $4.6M | $3.8M | $7.3M |
| Gross margin | — | — | — | 50.0% | 70.3% | 47.5% | 45.1% | 40.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$188.0K | −$15.0K | −$34.1K | −$3.9M | −$4.3M | −$4.0M | $11.9M | −$6.7M |
| EBITDA | −$15.0K | −$34.1K | −$23.5M | −$14.5M | −$1.5M | −$4.3M | −$31.3M | −$6.2M |
| Net income | −$188.0K | −$15.0K | −$34.1K | −$24.3M | −$15.4M | −$2.6M | −$16.1M | −$6.9M |
| Net margin | — | — | — | -920485.0% | -1591.7% | -26.8% | -192.8% | -38.2% |
| EPS (diluted) | -0.04 | -0.00 | -0.01 | -2.28 | -1.09 | -0.18 | -0.07 | -0.04 |
Annual figures · source: Financial Modeling Prep
INFUSION BRANDS INTL INC
No one on the platform currently holds INBI.
No tracked institution reports a position in INBI as of their last filing.
No one on the platform has traded INBI yet.
| +0.00% |
| $13983 |
| — |
| KPOCKimberly Parry Organics Inc. | $0.00 | +0.00% | $13743 | — |
| LEAILegacy Education Alliance, Inc. | $0.00 | +0.00% | $492 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$INBI - Infusion Brands Inte appears to be very risky… https://www.macroaxis.com/invest/market/INBI--diagnostics--Infusion-Brands-International #insidertrading #stocks #fintechnews
View on StockTwits ↗$INBI - Stable price overlap event (MAVP) detected for Infusion Brands, downward reversal… https://www.macroaxis.com/invest/Overlap-Studies/MAVP/INBI
View on StockTwits ↗$INBI - Pair correlation between… https://www.macroaxis.com/invest/market/INBI--compareProfile--PG #portfolio_prospective #better_portfolio #diversify
View on StockTwits ↗$INBI - Correlation between Infusion… http://dlvr.it/RRxfyc #portfolio_prospective #better_portfolio #diversify
View on StockTwits ↗Updated correlation matrix for Xylem($XYL), Infusion Brands($INBI), Interactive… http://dlvr.it/RKvsWB #correlations #stocks #stockratings
View on StockTwits ↗$INBI - INFUSION BRANDS INTE appears to be very risky and stock price may… https://www.macroaxis.com/invest/market/INBI--diagnostics--INFUSION-BRANDS-INTERNATIONAL-I #insidertrading #stocks #fintechnews
View on StockTwits ↗$INBI - The entity reported previous year revenue of 14.45M. Net Loss for the… https://www.macroaxis.com/invest/market/INBI--diagnostics--INFUSION-BRANDS-INTERNATIONAL-I #insidertrading #stocks #fintechnews
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.